Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
Ind-Ra maintains a neutral outlook for healthcare in FY23
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Announces pilot project for rapid, remote diagnosis of tuberculosis
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
Pilots to be launched across multiple locations in India.
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
It is currently available in tablet and injectable dosage forms
Subscribe To Our Newsletter & Stay Updated
